Vetiqure, sees a continuous great interest in the TSE technology from several veterinary clinics across northern
Since launching the TSE technology to veterinarians several cats and dogs has been treated with promising results.
The feasibility study, which Vetiqure is conducting in the US, is progressing better than expected and has so far shown a true need for this new innovation on the North American market. The progress has been confirmed by our collaborative partner in the US whom is also happy to report that he can see a tremendous interest and curiosity pertaining TSE after our first conference in the US.
We also had some in-depth discussions with potential distributors who has shown great interest in distributing our technology.
“After more than 18 months of pandemic barriers our marketing activities have been revived and we can once again visit our customers face to face. It feels really good to start the marketing and training, which after our CE-mark now also includes
For further information please contact:
+46 (0)10-218 93 00
ChemoTech is a Swedish medical technology company based in
(c) 2021 Cision. All rights reserved., source
Read more here: Source link